“Synthesis and biological screening of new derivatives of 2,3-dihydro quinazolin-4(1H)-one and benzotriazepin- 5(2H)-one for central nervous system activity”, Int J of Pharm Chem, vol. 4, no. 1, pp. 15–20, Feb. 2014, doi: 10.7439/ijpc.v4i1.63.